<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24749" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Marjolin Ulcer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Muneeb</given-names>
          </name>
          <aff>Penn State Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crane</surname>
            <given-names>Jonathan S.</given-names>
          </name>
          <aff>Sampson Regional Med Ctr / Campbell Univ</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muneeb Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jonathan Crane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24749.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A Marjolin ulcer is a cutaneous malignancy that arises in the setting of previously injured skin, longstanding scars, and chronic wounds. Historically, Marjolin ulcers are named for French surgeon Jean Nicolas Marjolin and first described as ulcerations with dense villi arising within a burn cicatrix. Squamous cell carcinoma is the most frequent malignancy identified, although other cell types have been described (i.e., basal cell carcinoma). Lesions are aggressive and carry a poor prognosis with a high rate of recurrence. This activity reviews the cause, pathophysiology, and presentation of Marjolin ulcer and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of Marjolin ulcer.</p></list-item><list-item><p>Review the evaluation of a patient with Marjolin ulcer.</p></list-item><list-item><p>Summarize the treatment options for Marjolin ulcer.</p></list-item><list-item><p>Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by Marjolin ulcers.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24749&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24749">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24749.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A Marjolin ulcer is a cutaneous malignancy that arises in the setting of previously injured skin, longstanding scars, and chronic wounds. Historically, Marjolin ulcers are named for French surgeon Jean Nicolas Marjolin and first described as ulcerations with dense villi arising within a burn cicatrix.<xref ref-type="bibr" rid="article-24749.r1">[1]</xref>&#x000a0;Squamous cell carcinoma is the most frequent malignancy identified, although other cell types have been described (i.e., basal cell carcinoma). Lesions are aggressive and carry a poor prognosis with a high rate of recurrence. Prevention with proper burn wound management and early recognition of malignant conversion followed by surgical resection, if possible,&#x000a0;are&#x000a0;of the utmost importance.</p>
      </sec>
      <sec id="article-24749.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Burn scars are the most common inciting condition that leads to the development of Marjolin ulcers.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref>&#x000a0;Malignant degeneration occurs in 0.7% to 2.0% of burn scars that have been allowed to heal by secondary intention.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r4">[4]</xref>&#x000a0;Other chronic inflammatory etiologies that lead to Marjolin ulcers include traumatic wounds, venous stasis ulcers, osteomyelitis, pressure ulcers, radiation dermatitis, stings, bites, and hidradenitis suppurativa.<xref ref-type="bibr" rid="article-24749.r1">[1]</xref><xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r4">[4]</xref><xref ref-type="bibr" rid="article-24749.r5">[5]</xref>&#x000a0;Individuals that are immunocompromised, either due to disease state or medication, are at increased risk for malignant conversion.<xref ref-type="bibr" rid="article-24749.r5">[5]</xref></p>
      </sec>
      <sec id="article-24749.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Marjolin ulcers occur in all age groups, sexes, and races.&#x000a0;The average latency period from the time of the initial inciting wound to the discovery of malignant degeneration is between 30 and 35 years, with the average age at presentation being 59 years.<xref ref-type="bibr" rid="article-24749.r6">[6]</xref><xref ref-type="bibr" rid="article-24749.r7">[7]</xref>&#x000a0;Men are more commonly affected than women (3:1), perhaps due to the increased frequency of burns&#x000a0;in this population&#x000a0;in general.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref>&#x000a0;Unlike other forms of skin cancer, the risk is equal in all races and ethnicities.<xref ref-type="bibr" rid="article-24749.r8">[8]</xref></p>
      </sec>
      <sec id="article-24749.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology has not been completely elucidated, but several mechanisms have been proposed, including chronic irritation, repeated re-epithelization, local damage to immune mechanisms of the skin, genetic predisposition, and toxins from local cell damage.<xref ref-type="bibr" rid="article-24749.r1">[1]</xref>&#x000a0;Burn scars tend to be raised above the natural skin, leading to chronic irritation. Obliteration of local lymphatic vessels, poor vascularization, and reduced Langerhans cell activity have been observed,&#x000a0;allowing developing lesions to avoid immune detection.<xref ref-type="bibr" rid="article-24749.r9">[9]</xref>&#x000a0;Overall, the pathogenesis is likely multifactorial, with chronic irritation and local toxins leading to neoplastic changes that are allowed to proliferate in the setting of altered immune mechanisms.</p>
      </sec>
      <sec id="article-24749.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Squamous cell carcinoma is the most frequent malignancy identified on histopathologic examination (80 to 90%).<xref ref-type="bibr" rid="article-24749.r2">[2]</xref>&#x000a0;Most lesions are well-differentiated, but poorly differentiated subtypes have also been identified. The second most common cell type is basal cell carcinoma (9.6%), followed by melanoma (2.4%). Rare cases of sarcoma,&#x000a0;dermatofibrosarcoma, mucoepidermoid carcinoma, and leiomyosarcoma have been described.<xref ref-type="bibr" rid="article-24749.r10">[10]</xref></p>
      </sec>
      <sec id="article-24749.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A nonhealing, ulcerative, or indurated lesion appearing in a chronic wound or scar should raise suspicion for malignant degeneration to a Marjolin ulcer.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref><xref ref-type="bibr" rid="article-24749.r7">[7]</xref>&#x000a0;Visually, the lesions have been described as ulcerative and foul-smelling with rapid growth and rolled elevated margins.<xref ref-type="bibr" rid="article-24749.r7">[7]</xref>&#x000a0;Other clinical signs that suggest Marjolin ulcer formation include exophytic granulation tissue, bleeding, and regional lymphadenopathy.<xref ref-type="bibr" rid="article-24749.r4">[4]</xref>&#x000a0;The ulcerative form is more common and more aggressive than the exophytic form. Superinfection of the wound may be the first presenting symptom. Lesions can occur anywhere but most frequently affect the lower extremities, followed by the scalp, upper extremities, torso, and face.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r10">[10]</xref>&#x000a0;Clinicians should pay close attention to all old scars on routine physical examinations and carefully note changes from prior visits.</p>
      </sec>
      <sec id="article-24749.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Any suspicious nonhealing or ulcerative lesion that appears in a chronic scar should be biopsied to confirm the diagnosis. Physical examination of local lymph nodes should be performed. Some centers perform an ultrasound of regional nodes due to the high rate of nodal involvement.<xref ref-type="bibr" rid="article-24749.r11">[11]</xref>&#x000a0;Lymphatic mapping and sentinel node biopsy have also been suggested.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref>&#x000a0;Other imaging (i.e., chest radiograph, brain computed tomography) can be considered on a case-by-case basis to assess for metastases.</p>
      </sec>
      <sec id="article-24749.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management should focus on prevention as unresected burn wounds that heal by secondary intention&#x000a0;are at increased risk for&#x000a0;malignant degeneration.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref>&#x000a0;Once discovered, no definitive treatment protocol exists for the management of Marjolin ulcers. The most widely accepted treatment options include Mohs surgery, wide local excision with 1 to 2 cm margins, and amputation proximal to the lesion.</p>
        <p>Mohs surgery can be considered in lesions on the face, scalp, hands, feet, areolae, and other areas where improved cosmesis is desired.<xref ref-type="bibr" rid="article-24749.r12">[12]</xref><xref ref-type="bibr" rid="article-24749.r13">[13]</xref>&#x000a0;Amputation is reserved for advanced-stage disease when wide local excision and Mohs surgery are not possible.<xref ref-type="bibr" rid="article-24749.r14">[14]</xref>&#x000a0;Defect coverage with local flap, free flap, or avascular graft is often performed but remains controversial as some studies have shown an increased risk of recurrence with incomplete resection.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r7">[7]</xref><xref ref-type="bibr" rid="article-24749.r15">[15]</xref>&#x000a0;After resection, close follow-up is necessary due to the high risk of recurrence.</p>
        <p>Lymph node dissection is controversial but can be considered with positive lymph nodes on physical or ultrasound examination.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r11">[11]</xref>&#x000a0;Adjuvant radiation and chemotherapy&#x000a0;are indicated if surgical resection is not possible. Agents that have been suggested include topical 5-fluorouracil, methotrexate, l-phenylalanine, and platinum-based therapy.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref><xref ref-type="bibr" rid="article-24749.r11">[11]</xref>&#x000a0;Radiotherapy is recommended with regional lymph node metastases, high-grade lesions (grade III), and lesions greater than 10 cm in diameter.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref></p>
      </sec>
      <sec id="article-24749.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Actinic keratosis</p>
          </list-item>
          <list-item>
            <p>Allergic contact dermatitis</p>
          </list-item>
          <list-item>
            <p>Atopic dermatitis</p>
          </list-item>
          <list-item>
            <p>Atypical fibroxanthoma</p>
          </list-item>
          <list-item>
            <p>Basal cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Benign cell lesions</p>
          </list-item>
          <list-item>
            <p>Bowenoid papulosis</p>
          </list-item>
          <list-item>
            <p>Chemical burns</p>
          </list-item>
          <list-item>
            <p>Limbal dermoid</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24749.s11" sec-type="Staging">
        <title>Staging</title>
        <p>No specific TNM staging criteria exist for Marjolin ulcers. After a biopsy has been performed, the histopathologic type of tumor can&#x000a0;be used to&#x000a0;stage the disease. For example, if the biopsy reveals squamous cell carcinoma, existing criteria established by the American Joint Committee on Cancer (AJCC) can be used.<xref ref-type="bibr" rid="article-24749.r2">[2]</xref></p>
      </sec>
      <sec id="article-24749.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although most Marjolin ulcers&#x000a0;are well-differentiated, lesions are aggressive and carry a poor prognosis. Metastases are found in up to 27% of patients compared to 3% for other causes of squamous cell carcinoma.<xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r7">[7]</xref><xref ref-type="bibr" rid="article-24749.r10">[10]</xref>&#x000a0;The recurrence rate after surgical resection is up to 50%<xref ref-type="bibr" rid="article-24749.r7">[7]</xref><xref ref-type="bibr" rid="article-24749.r10">[10]</xref>.&#x000a0;High grade (grade II or III), the presence of&#x000a0;nodal metastases, and lower extremity location indicate a worse prognosis.<xref ref-type="bibr" rid="article-24749.r1">[1]</xref><xref ref-type="bibr" rid="article-24749.r3">[3]</xref><xref ref-type="bibr" rid="article-24749.r10">[10]</xref>&#x000a0;The 5-year survival rate is 43 to 58%.<xref ref-type="bibr" rid="article-24749.r12">[12]</xref></p>
      </sec>
      <sec id="article-24749.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Marjolin ulcers most commonly arise from burn scars.</p>
          </list-item>
          <list-item>
            <p>The most common cell type identified is squamous cell carcinoma.</p>
          </list-item>
          <list-item>
            <p>All suspicious lesions should be biopsied.</p>
          </list-item>
          <list-item>
            <p>Confirmed cases of&#x000a0;Marjolin ulcers should be excised with clear margins.</p>
          </list-item>
          <list-item>
            <p>Marjolin ulcers can be prevented with early excision and grafting of burn wounds.</p>
          </list-item>
          <list-item>
            <p>Prognosis is poor with a high rate of recurrence.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24749.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Prevention and management of Marjolin ulcers require an interprofessional team approach, including providers from surgery, primary care, oncology, and dermatology.&#x000a0;Burn scars should be excised, and the surrounding skin should be reconstructed by a&#x000a0;surgeon trained in the reconstruction (i.e., plastic surgeon) to prevent malignant conversion. For burn scars that have been allowed to heal by secondary intention, primary care providers (physicians, nurse practitioners, and physician assistants) must be aware that burn scars are at risk for malignant conversion. All burn scars should be monitored on routine physical examination, and patients should be educated on symptoms to prompt earlier presentation.<xref ref-type="bibr" rid="article-24749.r12">[12]</xref>&#x000a0;[Level 5]</p>
        <p>Wound changes that are&#x000a0;suspicious for Marjolin ulcers should be immediately biopsied. Once malignancy has been identified, a team approach to management should be initiated. Staging should involve an examination of the regional lymph nodes, either by physical or ultrasound examination. If the malignancy is thought to be confined to the scar, treatment should be discussed with a surgical oncologist, plastic surgeon, and Mohs surgeon. Resection with wide margins or Mohs technique should be&#x000a0;performed depending on the location and desired cosmesis.<xref ref-type="bibr" rid="article-24749.r12">[12]</xref>&#x000a0;Radiation oncology and medical oncology should be consulted for adjuvant radiotherapy/chemotherapy for those with positive lymph nodes.</p>
        <p>After treatment, follow-up surveillance should occur regularly with a primary care provider or dermatologist to note any evidence of recurrence.</p>
      </sec>
      <sec id="article-24749.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24749&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24749">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/marjolin-ulcer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24749">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24749/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24749">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24749.s16">
        <title>References</title>
        <ref id="article-24749.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazali&#x00144;ski</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Przybek-Mita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bara&#x00144;ska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wi&#x00119;ch</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcer in chronic wounds - review of available literature.</article-title>
            <source>Contemp Oncol (Pozn)</source>
            <year>2017</year>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>197</fpage>
            <page-range>197-202</page-range>
            <pub-id pub-id-type="pmid">29180925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkins-Williams</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Marston</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Hultman</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Management of the Chronic Burn Wound.</article-title>
            <source>Clin Plast Surg</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>679</fpage>
            <page-range>679-687</page-range>
            <pub-id pub-id-type="pmid">28576257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Copcu</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcer: a preventable complication of burns?</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>124</volume>
            <issue>1</issue>
            <fpage>156e</fpage>
            <page-range>156e-164e</page-range>
            <pub-id pub-id-type="pmid">19568055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saaiq</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcers in the post-burned lesions and scars.</article-title>
            <source>World J Clin Cases</source>
            <year>2014</year>
            <month>Oct</month>
            <day>16</day>
            <volume>2</volume>
            <issue>10</issue>
            <fpage>507</fpage>
            <page-range>507-14</page-range>
            <pub-id pub-id-type="pmid">25325060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giesey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Delost</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Honaker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Metastatic squamous cell carcinoma in a patient treated with adalimumab for hidradenitis suppurativa.</article-title>
            <source>JAAD Case Rep</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>489</fpage>
            <page-range>489-491</page-range>
            <pub-id pub-id-type="pmid">29022006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleming</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Purdue</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Sandstad</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcer: a review and reevaluation of a difficult problem.</article-title>
            <source>J Burn Care Rehabil</source>
            <year>1990</year>
            <season>Sep-Oct</season>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>460</fpage>
            <page-range>460-9</page-range>
            <pub-id pub-id-type="pmid">2246317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pekarek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Osher</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A Comprehensive Review on Marjolin's Ulcers: Diagnosis and Treatment.</article-title>
            <source>J Am Col Certif Wound Spec</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>60</fpage>
            <page-range>60-4</page-range>
            <pub-id pub-id-type="pmid">24525526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradford</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Skin cancer in skin of color.</article-title>
            <source>Dermatol Nurs</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>170</fpage>
            <page-range>170-7, 206; quiz 178</page-range>
            <pub-id pub-id-type="pmid">19691228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CASTANARES</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Malignant degeneration in burn scars.</article-title>
            <source>Calif Med</source>
            <year>1961</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-7</page-range>
            <pub-id pub-id-type="pmid">13691372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadegh Fazeli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lebaschi</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Hajirostam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Keramati</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcer: clinical and pathologic features of 83 cases and review of literature.</article-title>
            <source>Med J Islam Repub Iran</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>215</fpage>
            <page-range>215-24</page-range>
            <pub-id pub-id-type="pmid">24926183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metwally</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Roshdy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ezzat</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and predictors of recurrence of Marjolin's ulcer: experience from Mansoura Universityxs.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-249</page-range>
            <pub-id pub-id-type="pmid">27791412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iqbal</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Marjolin's ulcer: a rare entity with a call for early diagnosis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Jul</month>
            <day>15</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26177995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Ad Hoc Task Force</collab>
              <name>
                <surname>Connolly</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Coldiron</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Fazio</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Storrs</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Vidimos</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Zalla</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Smith Begolka</surname>
                <given-names>W</given-names>
              </name>
              <collab>Ratings Panel</collab>
              <name>
                <surname>Berger</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Bigby</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bolognia</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Brodland</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cronin</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Grant-Kels</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hanke</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Hruza</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Lober</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McBurney</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Roenigk</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Wheeland</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Wisco</surname>
                <given-names>OJ</given-names>
              </name>
            </person-group>
            <article-title>AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>531</fpage>
            <page-range>531-50</page-range>
            <pub-id pub-id-type="pmid">22959232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Challa</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Deshmane</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ashwatha Reddy</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>A Retrospective Study of Marjolin's Ulcer Over an Eleven Year Period.</article-title>
            <source>J Cutan Aesthet Surg</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <page-range>155-9</page-range>
            <pub-id pub-id-type="pmid">25538436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24749.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oru&#x000e7;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kankaya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sungur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>&#x000d6;zer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>I&#x0015f;&#x00131;k</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Ulusoy</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Uysal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ko&#x000e7;er</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological evaluation of Marjolin ulcers over two decades.</article-title>
            <source>Kaohsiung J Med Sci</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>327</fpage>
            <page-range>327-333</page-range>
            <pub-id pub-id-type="pmid">28738972</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
